Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$16.35 - $21.4 $11,330 - $14,830
-693 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$16.34 - $25.24 $11,078 - $17,112
-678 Reduced 49.45%
693 $13,000
Q1 2020

May 15, 2020

SELL
$14.66 - $30.57 $22,312 - $46,527
-1,522 Reduced 52.61%
1,371 $23,000
Q4 2019

Feb 14, 2020

SELL
$22.45 - $27.09 $2,334 - $2,817
-104 Reduced 3.47%
2,893 $78,000
Q3 2019

Nov 14, 2019

BUY
$25.98 - $30.8 $1,688 - $2,002
65 Added 2.22%
2,997 $81,000
Q2 2019

Aug 14, 2019

BUY
$27.55 - $32.39 $26,640 - $31,321
967 Added 49.21%
2,932 $88,000
Q1 2019

May 15, 2019

BUY
$25.85 - $30.47 $21,791 - $25,686
843 Added 75.13%
1,965 $57,000
Q4 2018

Jan 31, 2019

BUY
$25.76 - $34.03 $28,902 - $38,181
1,122 New
1,122 $32,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.14B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.